SCHEMBL4178892

SCHEMBL4178892

COc1cc(OC)c(/C=C(\C(N)=O)S(=O)(=O)Cc2ccc(Cl)cc2Cl)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ FLT1 P17948 2/20 0.36
▸ FLT4 P35916 2/20 0.36
▸ KDR P35968 2/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36
▸ TUBA4A P68366 1/20 0.36
▸ TUBB4B P68371 1/20 0.36
▸ TUBB3 Q13509 1/20 0.36
▸ TUBB2A Q13885 1/20 0.36
▸ TUBB8 Q3ZCM7 1/20 0.36
▸ TUBA3E Q6PEY2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4178895 1.00 LMNA (0.41) LMNATDP1HDAC8KDM4EHTT
SCHEMBL4178898 1.00 LMNA (0.41) LMNATDP1HDAC8KDM4EHTT
SCHEMBL4172167 0.85 EGFR (0.40) LMNAHDAC8KDM4EMEN1KMT2A
SCHEMBL4172157 0.85 EGFR (0.40) LMNAHDAC8KDM4EMEN1KMT2A
SCHEMBL4172163 0.85 EGFR (0.40) LMNAHDAC8KDM4EMEN1KMT2A
SCHEMBL4175927 0.82 LMNA (0.41) LMNAHDAC8KDM4ETUBB4ATUBB
SCHEMBL4175935 0.82 LMNA (0.41) LMNAHDAC8KDM4ETUBB4ATUBB
SCHEMBL4175932 0.82 LMNA (0.41) LMNAHDAC8KDM4ETUBB4ATUBB
SCHEMBL4181334 0.80 LMNA (0.42) LMNATDP1HDAC8HTTSMN1; SMN2
SCHEMBL4181331 0.80 LMNA (0.42) LMNATDP1HDAC8HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 LMNA 4621/4885TDP1 4666/4885HDAC8 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback